Biden’s $7 billion price tag on plan to limit fallout from drug pricing changes

Published October 3, 2024 3:30pm ET



A plan from the Biden-Harris administration to lower insurance premium prices for seniors could cost more than $7 billion next year and $21 billion through 2027, according to a new report from the Congressional Budget Office. 

Republican lawmakers say the program to subsidize Medicare Part D prescription drug plans, announced this summer by the Centers for Medicare and Medicaid Services, is an attempt by Democrats to hide the rising costs of healthcare during the 2024 election.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.